OPHI logo

COLLPLANT BIOTECHNOLOGIES LT

OPHINASDAQ
๐Ÿ† #4806 by market capEarnings Dec 2US Equity
$3.13โ–ผ $0.08 (โˆ’2.49%)
Market closed ยท at close
๐Ÿ””
Track OPHI
Get earnings, price moves & breaking news on Telegram
Track
24hโ–ผ 2.5%
7dโ–ผ 13.4%
14dโ–ผ 22.8%
30dโ–ผ 12.1%
ytdโ–ผ 77.8%
1yโ–ผ 85.0%
๐ŸฆMarket Cap
$7M
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
-86.8%
Declining
๐Ÿ“ŠGross Margin
-321.7%
Thin
๐Ÿ’ตFCF Margin
โ€”
โš–๏ธP/S Ratio
27.6x
Expensive
Otter Score
โ€”
Insufficient data

Trading Snapshot

Day Range
$3.13 โ€“ $3.71
52-Week Range
$2.64 โ€“ $22.50
Volume (shares)
45,268
Avg Volume (shares)
โ€”
Shares Outstanding
2.3M
Next Earnings
2026-12-02

Fundamentals Snapshot

Annual Revenue
โ€”
Last Q Revenue
โ€”
P/E Ratio
โ€”
P/S Ratio
27.6x
EPS (TTM)
$-9.39
Dividend Yield
โ€”
OPHI logo

COLLPLANT BIOTECHNOLOGIES LT

OPHI
Financial Trends

Financial history unavailable.

StockOtter ยท stockotter.space

About COLLPLANT BIOTECHNOLOGIES LT

CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. It engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. Its products include VergenixSTR, VergenixFG, and Collink.3D. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.

๐Ÿฆฆ

Otter Score Breakdown

How it's scoredFive components, each rated 1โ€“5โ˜… and equally weighted (20%), averaged to a 0โ€“100 score:๐Ÿ’Ž Quality โ€” gross margin๐Ÿš€ Growth โ€” revenue YoYโš–๏ธ Valuation โ€” P/S ratioโšก Momentum โ€” 30-day price change๐Ÿ’ง Dilution โ€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Insufficient data
โ€”/100
Analyst data unavailable.

Latest News & Updates

News unavailable.